BiotechTube

YM150 + Warfarin

Phase 2Completed
1 views this week 0 watching💤 Quiet
Interest: 35/100
35
Hype Score

Development Stage

✓
Pre-clinical
✓
Phase 1
3
Phase 2
4
Phase 3
5
Approved
Indication / Disease

Atrial Fibrillation

Conditions

Atrial Fibrillation

Trial Timeline

Jun 1, 2009 → Sep 1, 2010

NCT ID
NCT00938730

About YM150 + Warfarin

YM150 + Warfarin is a phase 2 stage product being developed by Astellas Pharma for Atrial Fibrillation. The current trial status is completed. This product is registered under clinical trial identifier NCT00938730. Target conditions include Atrial Fibrillation.

What happened to similar drugs?

20 of 20 similar drugs in Atrial Fibrillation were approved

Approved (20) Terminated (4) Active (0)
✅OAC aloneDaiichi SankyoApproved
✅EdoxabanDaiichi SankyoApproved
✅Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
✅dapagliflozin + PlaceboAstraZenecaApproved
✅valsartanNovartisApproved
✅Apixaban + Parenteral heparin and/or oral Vitamin K antagonistPfizerApproved
✅Vitamin K antagonist + ApixabanPfizerApproved

Hype Score Breakdown

Clinical
12
Activity
8
Company
15
Novelty
0
Community
0

Clinical Trials (3)

NCT IDPhaseStatus
NCT00938730Phase 2Completed
NCT00595426Phase 2Completed
NCT00448214Phase 2Completed

Competing Products

20 competing products in Atrial Fibrillation

See all competitors
ProductCompanyStageHype Score
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Clopidogrel + Prasugrel + Ticagrelor + Vitamin K antagonistDaiichi SankyoPhase 3
40
OAC aloneDaiichi SankyoApproved
43
Edoxaban + ASADaiichi SankyoPhase 3
32
DU-176b tablets + DU-176b tablets + Warfarin tabletsDaiichi SankyoPhase 2
35
Edoxaban + Apixaban + RivaroxabanDaiichi SankyoPre-clinical
26
Edoxaban + VKA-Based Regimen + VKA-Based Regimen + VKA-Based Regimen + VKA-Based RegimenDaiichi SankyoPhase 3
40
Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + Edoxaban (DU-176b) + warfarinDaiichi SankyoPhase 2
35
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoApproved
43
Edoxaban + Warfarin + EnoxaparinDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b 15mg + DU-176b 30mg + DU-176b 60mgDaiichi SankyoPhase 3
40
dabigatran, rivaroxaban, apixaban or edoxabanDaiichi SankyoPre-clinical
22
EdoxabanDaiichi SankyoPre-clinical
26
DU-176b tablets + Warfarin potassium tabletsDaiichi SankyoPhase 2
35
Edoxaban-based Regimen + VKA-based RegimenDaiichi SankyoPhase 3
40
EdoxabanDaiichi SankyoPre-clinical
26
Edoxaban + Aspirin and Clopidogrel + Aspirin and WarfarinDaiichi SankyoApproved
39